A deep learning system for predicting time to progression of diabetic retinopathy.
Ling DaiBin ShengTingli ChenQiang WuRuhan LiuChun CaiLiang WuDawei YangHaslina HamzahYuexing LiuXiang-Ning WangZhouyu GuanShujie YuTingyao LiZiqi TangAn Ran RanHaoxuan CheHao ChenYingfeng ZhengJia ShuShan HuangChan WuShiqun LinDan LiuJiajia LiZheyuan WangZiyao MengJie ShenXuhong HouChenxin DengLei RuanFeng LuMiaoli CheeTen Cheer QuekRamyaa SrinivasanRajiv RamanXiaodong SunYa-Xing WangJiarui WuHai JinRongping DaiDinggang ShenXiaokang YangMinyi GuoCuntai ZhangCarol Y CheungGavin Siew Wei TanYih-Chung ThamChing-Yu ChengHuating LiTien-Yin WongWeiping JiaPublished in: Nature medicine (2024)
Diabetic retinopathy (DR) is the leading cause of preventable blindness worldwide. The risk of DR progression is highly variable among different individuals, making it difficult to predict risk and personalize screening intervals. We developed and validated a deep learning system (DeepDR Plus) to predict time to DR progression within 5 years solely from fundus images. First, we used 717,308 fundus images from 179,327 participants with diabetes to pretrain the system. Subsequently, we trained and validated the system with a multiethnic dataset comprising 118,868 images from 29,868 participants with diabetes. For predicting time to DR progression, the system achieved concordance indexes of 0.754-0.846 and integrated Brier scores of 0.153-0.241 for all times up to 5 years. Furthermore, we validated the system in real-world cohorts of participants with diabetes. The integration with clinical workflow could potentially extend the mean screening interval from 12 months to 31.97 months, and the percentage of participants recommended to be screened at 1-5 years was 30.62%, 20.00%, 19.63%, 11.85% and 17.89%, respectively, while delayed detection of progression to vision-threatening DR was 0.18%. Altogether, the DeepDR Plus system could predict individualized risk and time to DR progression over 5 years, potentially allowing personalized screening intervals.
Keyphrases
- diabetic retinopathy
- deep learning
- optical coherence tomography
- editorial comment
- type diabetes
- convolutional neural network
- cardiovascular disease
- artificial intelligence
- machine learning
- electronic health record
- resistance training
- weight loss
- adipose tissue
- body composition
- quantum dots
- drug induced
- breast cancer risk